EUVIMEDEUVIMED entdecken
Crossref

HLA Class I Genotype as a Determinant of Human Endogenous Retrovirus-Derived Peptide Presentation and Response to Immune Checkpoint Inhibitors in Cancer: A Mechanistic and Translational Review

Ahmed Sohaib

Annals of Cancer Research and Therapy · 2026 · 34 (2) · 65-73

DOI: 10.4993/acrt.34.65 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Cancer Research and Therapy, 2026. Verfasst von Ahmed Sohaib. Die Arbeit nennt 37 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Sohaib, A. (2026). HLA Class I Genotype as a Determinant of Human Endogenous Retrovirus-Derived Peptide Presentation and Response to Immune Checkpoint Inhibitors in Cancer: A Mechanistic and Translational Review. Annals of Cancer Research and Therapy, 34(2), 65-73. https://doi.org/10.4993/acrt.34.65

Vancouver

Sohaib A. HLA Class I Genotype as a Determinant of Human Endogenous Retrovirus-Derived Peptide Presentation and Response to Immune Checkpoint Inhibitors in Cancer: A Mechanistic and Translational Review. Annals of Cancer Research and Therapy. 2026;34(2):65-73. doi:10.4993/acrt.34.65

BibTeX
@article{Sohaib2026,
  author = {Sohaib, Ahmed},
  title = {HLA Class I Genotype as a Determinant of Human Endogenous Retrovirus-Derived Peptide Presentation and Response to Immune Checkpoint Inhibitors in Cancer: A Mechanistic and Translational Review},
  journal = {Annals of Cancer Research and Therapy},
  year = {2026},
  volume = {34},
  number = {2},
  pages = {65--73},
  doi = {10.4993/acrt.34.65}
}
Kostenlos starten →